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Clathrin-dependent endocytic pathway is crucial for cell entry of extracellular pathogens and their components. 
The innate immune system utilizes this pathway to detect pathogen-associated molecular patterns (PAMPs) 
within endosomes. In the clathrin-mediated endocytosis, cargo selection depends on AP-2 adaptor and its 
accessory proteins, but the molecular mechanism of PAMP selection to be internalized is largely unknown. The 
endosomal Toll-like receptors (TLRs) 3, 7, 8, and 9 recognize viral or bacterial nucleic acids, as well as 
host-derived nucleic acids incorporated into the endosomal compartments, where type I interferon 
(IFN)-producing signals are arisen. In addition, lipopolysaccharide (LPS) receptor TLR4 transmits signals to 
produce IFN- from endosomes after the clathrin-dependent endocytosis of LPS-TLR4. The cytosolic protein 
Raftlin that possesses membrane-anchoring motif mediates cellular uptake of TLR3/4 ligands in human cells 
through association with clathrin-AP-2 complex. Raftlin was first identified as a major raft protein in B cells 
that modulates B-cell or T-cell receptor-mediated signaling. In this review, we will focus on the Raftlin function 
in innate immunity and discuss the molecular mechanisms of cellular uptake and delivery of TLR ligands. 
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Introduction 
Innate immune system is essential for induction of 
adaptive immunity. A variety of soluble and 
membrane-bound pattern-recognition receptors (PRRs) have 
been provided to sense microbial infection, which elicit 
anti-microbial immune responses [1-3]. Toll-like receptors 
(TLRs), a type I transmembrane protein family, recognize 
pathogen-associated molecular patterns (PAMPs) such as 
lipopolysaccharide (LPS), peptidoglycan and viral nucleic 
acids, and transmit signals linking innate and adaptive 
immunity [3]. TLRs also detect self-molecules derived from 
damaged or dying cells, which promotes inflammatory 
response and development of autoimmune disorders [4, 5]. 
Among human TLRs 1-10, the nucleic acid-sensing TLRs 3, 
7, 8 and 9 localize to the endosomal compartments, where 
they encounter the incorporated viral- or host-derived nucleic 
acids and induce type I interferon (IFN) and proinflammatory 
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cytokine production [6-9]. Although cell surface receptors 
involving in the uptake and delivery of extracellular nucleic 
acids (exNAs) have not been fully identified, accumulating 
evidence demonstrate that clathrin-dependent endocytic 
pathway plays an important role in cellular uptake of exNAs 
including polyinocinic:polycytidylic acid (poly(I:C)) and 
CpG oligodeoxynucleotides (ODNs) [10, 11]. In addition, 
cell-surface TLR4 is internalized in the clathrin- and 
dynamin-dependent manner after the binding to LPS [12] to 
induce IFN- -IL-1 receptor 
domain-containing adaptor molecule (TICAM)-2 (also called 
TRAM) and TICAM-1 (also called TRIF) [13-15]. Thus, innate 
immune system utilizes endocytic pathway to detect 
extracellular microbial components, but precise molecular 
mechanisms of PAMP loading remain unknown. Recently, 
we have reported that the cytosolic protein Raftlin that 
possesses membrane-anchoring motif mediates cellular 
uptake of poly(I:C), CpG ODNs and LPS in human dendritic 
cells (DCs), macrophages and epithelial cells through 
association with clathrin-AP-2 complex [16,17]. In this review, 
we will summarize the molecular mechanisms of exNA 
internalization and focus on the role of Raftlin in the 
regulation of endosomal TLR signaling.  
Raftlin function in adaptive immunity 
Raftlin was first identified as a major raft protein in 
human B cell line, Raji, by proteome analysis [18]. Like Src 
family protein tyrosine kinase such as Lck and Lyn that 
localize in lipid rafts, Raftlin possesses the N-terminal fatty 
acylation sites. The Gly2 N-myristoylation site and the Cys3 
S-palmitoylation site are important for localization of Raftlin 
in lipid rafts. Raftlin colocalized with B-cell receptor (BCR) 
before and after BCR stimulation in human B cells, but their 
direct interaction was undetected by immunoprecipitation 
assay. Using Raftlin-deficient DT40 chicken B cells, Raftlin 
was shown to act as a positive regulator of BCR signal 
transduction through the maintenance of lipid raft and 
recruitment of raft proteins [18]. 
The physiological function of Raftlin was subsequently 
analyzed by generating Raftlin-deficient mice, which 
demonstrated the normal B cell signals. Mouse B cells 
express a Raftlin-homologue, Raftlin-2 that might 
compensate Raftlin function in Raftlin-deficient B cells [19]. 
On the other hand, in Raftlin-deficient T cells that do not 
express Raftlin-2, T-cell receptor (TCR)-mediated cytokine 
production, especially IL-17 production was reduced. In 
addition, T-cell-dependent antibody production was impaired 
in Raftlin-deficient mice. Raftlin uniformly localized on the 
plasma membrane of T cells, and is accumulated in the 
immunological synapse upon TCR stimulation [19]. Based on 
the biochemical analyses, Raftlin appears to influence the 
accumulation of tyrosine kinase Lck into lipid rafts, resulting 
in the modulation of TCR signaling including tyrosine 
phosphorylation of the signaling molecules and intracellular 
Ca2+ mobilization [19]. Thus, Raftlin localizes to lipid rafts in 
B- and T-cells and is involved in BCR- and TCR-mediated
signaling in adaptive immunity.
Raftlin function in innate immunity 
Sensing exNAs by endosomal TLRs 
TLR3 recognizes viral double-stranded (ds) RNA [20,21] 
and incomplete stem structures formed in viral 
single-stranded (ss) RNA [22], TLR7 and TLR8 sense viral 
ssRNA and synthetic imidazoquinoline compounds [23-26], 
and TLR9 recognizes unmethylated CpG-containing DNA [27,
28]. TLR3, 8 reside in the early endosome of myeloid 
dendritic cells (DCs), whereas TLR7, 9 present in the 
endolysosome of plasmacytoid DCs and B cells. All of these 
TLRs require an endoplasmic reticulum (ER)-resident 
multi-transmembrane protein Unc93B1 and LRRC59 to exit 
ER and traffic to the distinct endosomal compartments [29-33], 
where they undergo proteolytic processing to generate 
functional cleaved/associated form of receptors [9, 34-38]. 
Internalization and delivery of ligands to the distinct 
organelles is prerequisite for endosomal TLR-initiated innate 
immune responses. 
Notably, endosomal TLRs are involved in the recognition 
of self nucleic acids released from damaged or dying cells [4,
5]. TLR7 and TLR9 are closely associated with autoimmune 
diseases through induction of type I IFNs and antibody 
production against self-RNA/DNA [4, 5]. Recent study using 
human TLR8-transgenic mice clearly demonstrated the 
connection between TLR8 and autoimmune inflammation [39]. 
In addition, TLR3 recognizes self noncoding RNA derived 
from stressed or necrotic cells, and induces IFN- and 
proinflammatory cytokines [40]. However, molecular structure 
of endogenous nucleic acids recognized by these TLRs and 
their recognition mechanisms remain to be elucidated. 
Raftlin is essential for clathrin-dependent endocytosis of 
TLR3 ligands 
Human TLR3 localizes both on the cell surface and 
endosomal membrane in fibroblasts, macrophages and 
epithelial cells [21], while myeloid DCs express TLR3 
intracellularly [6]. Although cell-surface TLR3 appears to 
recognize poly(I:C) since anti-human TLR3 mAb inhibits 
poly(I:C)-induced IFN- production from fibroblasts [21], 
TLR3-mediated signaling arises from the endosomes in both 
cell types. Upon ligand recognition in the endosomes, TLR3 
transmits signals via an adaptor protein TICAM-1 that 
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Table 1. Molecules involving in the internalization of poly(I:C)/ODN 
Proteins NAs Cell Localization Function Ref. 









SR-A poly(I:C) human bronchial epithelial 
cell BEAS-2B, primary 
human bronchial epithelia 




SR-As viral dsRNA 
(200, 1000bp) 
MEFs, human fibroblasts cell surface binding 46 
CD11b/CD18 poly(I:C) (300-750 bp) peritoneal macrophages, 
RAW264.7 
cell surface direct binding, 
endocytosis 
47 
Raftlin poly(I:C), structured 




DCs, human epithelial cell 







RAGE CpG ODN 
(A/C-type>B-type) 




DEC205 B/C-type CpG ODN (for 
mouse DEC205) B-type 
CpG ODN (for human 
DEC205) 
CHO-K1/DEC205, mouse 
CD8+ DC, mouse B cell 








ARF6 B-type CpG ODN RAW264.7 cell surface regulate cellular 
uptake 
61 
activates the transcription factors IRF3, NF-B, and AP-1, 
leading to induction of type I IFN and inflammatory cytokine 
production as well as DC maturation [11, 41, 42]. Poly(I:C), a 
synthetic viral dsRNA analog, is a potent TLR3 agonist that 
is efficiently internalized into cells and activates endosomal 
TLR3 [11]. Curiously, in vitro transcribed dsRNAs (100 
bp~1000bp) that are functional when directly delivered to 
endosomes are unable to activate TLR3 when extracellulary 
added to human myeloid DCs [43], suggesting the failure of 
dsRNA uptake in contrast to poly(I:C).  
Using proteome analyses of poly(I:C)-binding proteins, 
we identified the cytoplasmic protein Raftlin as a component 
of clathrin-dependent endocytic machinery of poly(I:C) [16]. 
When Raftlin was knocked down in human myeloid DCs and 
epithelial cells, extracellular poly(I:C) failed to enter cells, 
remaining on the cell surface as speckles. Clustering of the 
uptake receptor occurs without internalization in Raftlin 
knockdown cells. Accordingly, TLR3-mediated IFN- 
production was never induced. In myeloid DCs and epithelial 
cells, Raftlin predominantly resides in the cytosol in contrast 
to the lipid raft localization in B and T cells. Upon poly(I:C) 
stimulation, Raftlin translocates from the cytosol to the 
plasma membrane, where it co-localizes with poly(I:C) and 
then trafficked to the TLR3-positive endosomes along with 
poly(I:C). Immunoprecipitation analysis demonstrated that 
Raftlin physically associates with clathrin heavy chain after 
poly(I:C) stimulation and then dissociated [16]. Hence, Raftlin 
is recruited to the plasma membrane when poly(I:C) bound 
to the uptake receptor, where associates with clathrin to 
modulate cargo sorting and delivery. In steady state, Raftlin 
interacts with clathrin adaptor AP-2 -subunit [17], suggesting 
that Raftlin regulates clathrin-dependent endocytosis of 
poly(I:C) as an accessory molecule of AP-2 through 
recognition of poly(I:C)-uptake receptor. Notably, 
internalization of transferin is independent of Raftlin 
irrespective of its dependency of clathrin [16].   
Besides dsRNA, TLR3 recognizes incomplete stem 
structures formed in viral ssRNA [22] and self stem-loop RNA 
derived from damaged or dying cells [40]. Extracellular 
virus-derived ‘structured’ RNAs that contain incomplete 
stems and show nuclease-resistant feature are internalized 
Raftlin-dependently similar to poly(I:C) uptake [22]. 
Structured RNA-induced TLR3-mediated IFN- and 
cytokine production did not occur when Raftlin was knocked 
down. Hence, Raftlin cooperates with the uptake receptor to 
mediate cell entry of ds/structured RNA, which is critical for 
activation of TLR3 (Figure 1).  
Importantly, Raftlin homolog, Raftlin2, is expressed in a 
species- and cell type-specific manner [16, 17, 19]. Human 
myeloid DCs and epithelial cells express only Raftlin, while 
mouse conventional DCs express Raftlin2 in addition to 
Raftlin. Poly(I:C) is internalized in Raftlin-deficient mouse 
DCs, but not in Raftlin-/-/ Raftlin2-/- DCs, suggesting that 
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Raftlin-2 functionally compensates for Raftlin in mouse DCs 
[16,17]. 
Raftlin mediates cell entry of phosphorothioated ODNs 
In human myeloid DCs and epithelial cells, B/C-type, but 
not A-type, CpG (TLR9 agonist) or GpC (TLR9 non-agonist) 
ODNs inhibited cellular binding and uptake of poly(I:C), and 
vice versa [10]. Raftlin-knocked down HEK293 cells failed to 
take up B/C-type CpG ODN and abolished TLR9-driven 
NF-B activation [16]. It appears that B/C-type ODNs share 
the uptake receptor with poly(I:C) and their internalization is 
regulated by Raftlin. B/C-type ODNs are fully 
phosphorothioated, while A-type ODNs are phosphodiester 
linkage. Hence, the structural feature of nucleic acids 
recognized by common uptake receptor for poly(I:C)/ODN is 
not simple, but is a nuclease-resistant structure.   
Uptake receptor for exNAs 
The uptake receptors for poly(I:C) or CpG ODNs have 
been reported by several groups (Table 1). The 
membrane-bound CD14 enhanced poly(I:C)-mediated TLR3 
activation in mouse macrophages by facilitating uptake of 
poly(I:C) into an intracellular compartment [44]. The 
scavenger receptor class-A (SR-A) was also identified as a 
cell surface receptor for poly(I:C) in human bronchial 
epithelial cells and mouse cells [45, 46]. Limmon et al. showed 
that SR-A antagonists or anti-SR-A antibody inhibited 
poly(I:C)-induced cytokine production in human bronchial 
epithelial cell line [46]. Moreover, CD11b/CD18 (CR3) was 
found to be a surface receptor for poly(I:C) to mediate 
cellular responses in mouse macrophages [47]. CR3 bound 
~200bp-length short poly(I:C) and facilitated the 
internalization of short poly(I:C). However, knockout of 
these molecules resulted in only partial abrogation of 
poly(I:C)-induced TLR3 activation [44-47], suggesting a 
redundant or cell type-specific function of these receptors in 
poly(I:C) internalization. Indeed, human myeloid DCs do not 
express CD14 on the cell surface and an inhibitor for SR-A 
does not affect poly(I:C) uptake in human myeloid DCs and 
epithelial cells (Matsumoto et al, unpublished data), 
indicating the presence of another uptake receptor in those 
cells.  
Figure 1. TLR3-mediated signaling. Extracellular poly(I:C) and structured RNA are recognized by cell 
surface uptake receptor and delivered to the TLR3-resident endosomes through Rarftlin- and 
clathrin-dependent endocytosis in human myeloid DCs and epithelial cells. Upon ligand recognition, TLR3 
activates IRF3 and NF-B via TICAM-1, leading to production of type I IFN and inflammatory cytokines, 
respectively.  
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Concerning DNA receptors, the receptor for advanced 
glycation end-products (RAGE) bound directly to both DNA 
and RNA oligonucleotide and promoted ODN uptake into 
endosomes [48]. B-type CpG ODN bound to RAGE more 
efficiently than A-type CpG ODN in solution, but cell 
surface RAGE expressed on HEK293T cells was associated 
with A-type CpG ODN more prevalently than with B-type 
CpG ODN and enhanced CpG-A ODN uptake [48]. 
Additionally, DEC-205 has been recently identified as an 
uptake receptor for B/C-type, but not A-type CpG ODNs in 
mouse cells [49]. Lahoud et al. demonstrated that human 
DEC-205 preferentially bound B-type, but not C-type, CpG 
ODN in in vitro binding assay [49]. In our experiments, 
however, human DEC-205 does not involved in 
poly(I:C)-induced TLR3 activation (Tatematsu and 
Matsumoto, unpublished data). Hence, these molecules 
appear to be independent on the uptake of poly(I:C) and 
B/C-type ODN in human DCs/epithelial cells. It appears that 
several uptake machinery participate in the cell entry of 
extracellular RNAs/DNAs in a cell type- and/or 
species-specific manner. 
Involvement of Raftlin in the TLR4-TICAM-1 signaling 
Besides nucleic acid-sensing TLRs, TLR4 transmits 
signals to produce IFN- from endosomes via 
TICAM-2-TICAM-1 signaling pathway in response to 
extracellular LPS [13-15]. Upon LPS recognition, TLR4-MD-2 
complex undergoes dimerization, which activates 
TIRAP-MyD88 signaling pathway at the plasma membrane 
resulting in the NF-B-driven proinflammatory cytokine 
production [50]. LPS-bound TLR4 is then internalized into the 
endosomes in a clathrin- and dynamin-dependent manner [12], 
where activates TICAM-2-TICAM-1 signaling pathway 
resulting in the activation of IRF3 leading to production of 
IFN-. The subcellular shuttling of TLR4 and switching of 
the signaling complex are regulated by several mechanisms. 
Kagan and colleagues demonstrated that the membrane 
bound CD14 controls LPS-induced TLR4 endocytosis in 
mouse macrophages and DCs [51]. The tyrosine kinase Syk 
Figure 2. TLR4-mediated signaling. Extracellular LPS is recognized by cell surface TLR4-MD-2 complex 
cooperatively with CD14, which recruits TIRAP/Mal and MyD88 at the plasma membrane and activates 
NF-B to induce inflammatory cytokine production (MyD88-dependent pathway). LPS-TLR4 is subsequently 
internalized into the endosomes via Raftlin- and clathrin-dependent endocytosis in human macrophages and 
DCs, where TICAM-2-TICAM-1-mediated IRF3 activation occurs, leading to production of IFN- 
(TICAM-1-dependent pathway). 
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and PLC2 regulate this process dependent on CD14 but 
independent of TLR4 [51]. Furthermore, the p110 isoform of 
PI(3)K acts as a regulator of TLR4 endocytosis in mouse 
DCs through modulating PtdIns(4,5)P2 metabolism [52].  
We have studied about the role of Raftlin in LPS-induced 
TLR4-mediated signaling and found that LPS-induced IFN- 
promoter activation, but not NF-B activation, was impaired 
in Raftlin knockdown HEK293 cells overexpressing human 
TLR4/MD-2 or TLR4/MD-2/CD14 [17]. The LPS-induced 
IFN- production was also decreased in Raftlin knockdown 
human monocyte-derived macrophages and DCs. Raftlin was 
resided in the cytoplasm in human macrophages and moved 
to the plasma membrane upon LPS stimulation, where it 
colocalized with TLR4 followed by internalization along 
with TLR4 [17]. Raftlin physically associates with TLR4 and 
clathrin in response to LPS stimulation, suggesting the 
involvement in the Raftlin- and clathrin-dependent TLR4 
endocytosis (Figure 2). Notably, Raftlin/Raftlin-2 participates 
in LPS-induced IFN- production in mouse splenic DCs, but 
not in bone marrow-derived macrophages (BMDMs) [17], 
indicating that Raftlin controls LPS-induced TLR4 
internalization and TICAM-1 signaling in a cell type-specific 
manner. Because surface CD14 level of BMDMs is higher 
than that of splenic DCs and human monocyte-derived DCs 
and macrophages express CD14 negative and low, 
respectively, surface CD14 level might affect the dependency 
of Raftlin in TLR4 endocytosis upon LPS stimulation. Taken 
together, Raftlin regulates TLR3- and TLR4-mediated 
endosomal TICAM-1 signaling through the induction of 
ligand uptake.   
Perspectives 
The synthetic ligands for endosomal TLRs have been 
applied to next generating vaccine adjuvants for infectious 
diseases and tumors [53, 54]. Especially, synthetic 
TLR3-specific ligand is a pivotal vaccine adjuvant for 
antitumor immunotherapy [55]. Since adjuvants are mainly 
targeted to antigen-presenting DCs to activate adaptive 
immunity [56], efficient delivery of TLR ligands into the 
endosomes of DCs is important in the efficacy of vaccine 
treatments. The elucidation of molecular mechanisms of how 
synthetic TLR ligands are internalized is important for the 
development of novel adjuvants. Recent studies on the 
molecular mechanisms of TLR ligand uptake implicate that 
there are several cell surface receptors mediating endocytosis 
of TLR ligands, which work species- and cell type-dependent 
manner. In addition, endocytic pathway is regulated by 
several molecules/mechanisms including accessory proteins 
for clathrin adaptor AP-2, Rab GTPases and the 
phosphatidylinositide conversion [57-59]. In human myeloid 
DCs and epithelial cells, Raftlin is required for endocytosis 
of poly(I:C) and poly(I:C)-induced TLR3-mediated signaling, 
although poly(I:C) uptake receptor recognized with Raftlin 
remains to be identified. Mass analysis of Raftlin-associating 
molecules in human epithelial cells has revealed that several 
molecules related to clathrin-dependent endocytosis are 
interacted with Raftlin [17]. Further study on the 
Raftlin-associating proteins provides new insight into the 
clathrin-mediated endocytic pathway in innate immunity.  
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